Cerba's buyout debt shown to earybirds in a bid to ditch bonds: Reuters
A €1.1 billion (US$1.2 billion) leveraged financing backing a buyout of European medical laboratory services operator Cerba is being shown to early-bird investors in a bid to gauge appetite for the deal, sources told Reuters. JP Morgan, Natixis, Credit Suisse, Deutsche Bank and BNP Paribas are leading the debt financing, which is currently split between a leveraged loan and a high-yield bond. Partners Group and Canada's PSP Investments agreed to acquire Cerba from PAI Partners, the firms announced in January. The terms weren't disclosed.
1 March 2017•2 mins read
